MLL5/KMT2E antibody
Quick Overview for MLL5/KMT2E antibody (ABIN7116572)
Target
See all MLL5/KMT2E (MLL5) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- KMT2E antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- myeloid/lymphoid or mixed-lineage leukemia 5(trithorax homolog, Drosophila)
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months
-
Expiry Date
- 12 months
-
-
- MLL5/KMT2E (MLL5) (Myeloid/lymphoid Or Mixed-Lineage Leukemia 5 (Trithorax Homolog) (MLL5))
-
Alternative Name
- KMT2E
-
Background
- Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E)|Myeloid/lymphoid or mixed-lineage leukemia protein 5|KMT2E|MLL5
-
Molecular Weight
- 100 kDa, 70 kDa
-
UniProt
- Q8IZD2
-
Pathways
- Retinoic Acid Receptor Signaling Pathway, Warburg Effect
Target
-